Self and Nonself Recognition by Coreceptors on B Lymphocytes: Regulation of B Lymphocytes by CD19, CD21, CD22, and CD72

  • Kozo Watanabe
  • Takeshi Tsubata


B-cell antigen receptor (BCR) signaling plays an essential role in regulation of the development and function of B lymphocytes (see Chapter 4). These signals are modulated by coreceptors expressed on the surface of B cells, including CD19, CD21 (complement receptor 2, CR2), CD22, CD72 (Lyb-2), and low-affinity receptor for IgG (FcγRII) (see Chapter 6 on Fc receptors). When CD19/CD21 complex is colligated with BCR, this complex positively regulates BCR signaling through the recruitment of signaling molecules, such as a phosphatidylinositol 3-kinase (PI3K), to their phosphorylated tyrosines. On the other hand, CD22 and CD72 negatively regulate BCR signaling through the recruitment of the SH2-domain-containing protein tyrosine phosphatase-1 (SHP-1) to their phosphorylated immunoreceptor tyrosine-based inhibitory motifs (ITIMs). From the characterization of each of these coreceptors deficient mice, now it is clear that the regulations by these coreceptors physiologically play a significant role in the development, activation, proliferation and differentiation of B cells. Importantly, these coreceptors are able to detect and respond to extracellular environment and modulate BCR signaling by their ligand bindings. These functions contribute to the recognition of self- and nonself-antigens (Ags), in some cases, in cooperation with the innate immune system, such as the recognition of activated complement fragments by CD21 (see Chapter 1 on innate immunity). In this chapter, we focus on the physiological function of the CD19, CD21, CD22, and CD72 and their molecular mechanisms involving signal transduction by these coreceptors, which will help us to understand how B cells recognize self and nonself.


Sialic Acid Complement Receptor Sialic Acid Recognition Semaphorin CD100 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adachi T, Flaswinkel H, Yakura H, Reth M, Tsubata T (1998) The B-cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J Immunol 160:4662–4665PubMedGoogle Scholar
  2. Adachi T, Wakabayashi C, Nakayama T, Yakura H, Tsubata T (2000) CD72 negatively regulates signaling through the antigen receptor of B cells. J Immunol 164:1223–1229PubMedGoogle Scholar
  3. Adachi T, Wienands J, Wakabayashi C, Yakura H, Reth M, Tsubata T (2001) SHP-1 requires inhibitory co-receptors to down-modulate B-cell antigen receptor-mediated phosphorylation of cellular substrates. J Biol Chem 276:26648–26655PubMedGoogle Scholar
  4. Ahearn JM, Fischer MB, Croix D, Goerg S, Ma M, Xia J, Zhou X, Howard RG, Rothstein TL, Carroll MC (1996) Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B-cell response to T-dependent antigen. Immunity 4:251–262PubMedGoogle Scholar
  5. Angelisova P, Hilgert I, Horejsi V (1994) Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins. Immunogenetics 39:249–256PubMedGoogle Scholar
  6. Aubry JP, Pochon S, Graber P, Jansen KU, Bonnefoy JY (1992) CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505–507PubMedGoogle Scholar
  7. Bakker TR, Piperi C, Davies EA, Merwe PA (2002) Comparison of CD22 binding to native CD45 and synthetic oligosaccharide. Eur J Immunol 32:1924–1932PubMedGoogle Scholar
  8. Barrington RA, Zhang M, Zhong X, Jonsson H, Holodick N, Cherukuri A, Pierce SK, Rothstein TL, Carroll MC (2005) CD21/CD19 coreceptor signaling promotes B-cell survival during primary immune responses. J Immunol 175:2859–2867PubMedGoogle Scholar
  9. Behr S, Schriever F (1995) Engaging CD19 or target of an antiproliferative antibody 1 on human B lymphocytes induces binding of B cells to the interfollicular stroma of human tonsils via integrin alpha 4/beta 1 and fibronectin. J Exp Med 182:1191–1199PubMedGoogle Scholar
  10. Biancone L, Bowen MA, Lim A, Aruffo A, Andres G, Stamenkovic I (1996) Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes. J Exp Med 184:811–819PubMedGoogle Scholar
  11. Bikah G, Lynd FM, Aruffo AA, Ledbetter JA, Bondada S (1998) A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5. Int Immunol 10:1185–1196PubMedGoogle Scholar
  12. Birkenbach M, Tong X, Bradbury LE, Tedder TF, Kieff E (1992) Characterization of an Epstein-Barr virus receptor on human epithelial cells. J Exp Med 176:1405–1414PubMedGoogle Scholar
  13. Boackle SA, Holers VM, Chen X, Szakonyi G, Karp DR, Wakeland EK, Morel L (2001) Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15:775–785PubMedGoogle Scholar
  14. Bottger EC, Metzger S, Bitter-Suermann D, Stevenson G, Kleindienst S, Burger R (1986) Impaired humoral immune response in complement C3-deficient guinea pigs: absence of secondary antibody response. Eur J Immunol 16:1231–1235PubMedGoogle Scholar
  15. Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF (1992) The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 149:2841–2850PubMedGoogle Scholar
  16. Braesch-Andersen S, Stamenkovic I (1994) Sialylation of the B lymphocyte molecule CD22 by alpha 2,6-sialyltransferase is implicated in the regulation of CD22-mediated adhesion. J Biol Chem 269:11783–11786PubMedGoogle Scholar
  17. Brinkman-Van der Linden EC, Sjoberg ER, Juneja LR, Crocker PR, Varki N, Varki A (2000) Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs. J Biol Chem 275:8633–8640PubMedGoogle Scholar
  18. Brooks SR, Li X, Volanakis EJ, Carter RH (2000) Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C, Vav and of Grb2 and Sos with different CD19 tyrosines. J Immunol 164:3123–3131PubMedGoogle Scholar
  19. Buhl AM, Cambier JC (1999) Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B-cell antigen receptor-mediated activation of Bruton’s tyrosine kinase. J Immunol 162:4438–4446PubMedGoogle Scholar
  20. Buhl AM, Pleiman CM, Rickert RC, Cambier JC (1997) Qualitative regulation of B-cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization. J Exp Med 186:1897–1910PubMedGoogle Scholar
  21. Callea V, Comis M, Iaria G, Sculli G, Morabito F, Lombardo VT (1997) Clinical significance of HLA-DR+, CD19+, CD10+ immature B-cell phenotype and CD34+ cell detection in bone marrow lymphocytes from children affected with immune thrombocytopenic purpura. Haematologica 82:471–473PubMedGoogle Scholar
  22. Campbell MA, Klinman NR (1995) Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C. Eur J Immunol 25:1573–159PubMedGoogle Scholar
  23. Carter RH, Fearon DT (1992) CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105–107PubMedGoogle Scholar
  24. Carter RH, Tuveson DA, Park DJ, Rhee SG, Fearon DT (1991) The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. J Immunol 147:3663–3671PubMedGoogle Scholar
  25. Carter RH, Doody GM, Bolen JB, Fearon DT (1997) Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the Bcell antigen receptor complex. J Immunol 158:3062–3069PubMedGoogle Scholar
  26. Chalupny NJ, Kanner SB, Schieven GL, Wee SF, Gilliland LK, Aruffo A, Ledbetter JA (1993) Tyrosine phosphorylation of CD19 in pre-B and mature B cells. EMBO J 12:2691–2696PubMedGoogle Scholar
  27. Chalupny NJ, Aruffo A, Esselstyn JM, Chan PY, Bajorath J, Blake J, Gilliland LK, Ledbetter JA, Tepper MA (1995) Specific binding of Fyn and phosphatidylinositol 3-kinase to the B-cell surface glycoprotein CD19 through their src homology 2 domains. Eur J Immunol 25:2978–2984PubMedGoogle Scholar
  28. Chan VW, Lowell CA, DeFranco AL (1998) Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr Biol 8:545–553PubMedGoogle Scholar
  29. Chen Z, Koralov SB, Gendelman M, Carroll MC, Kelsoe G (2000) Humoral immune responses in Cr2-/-mice: enhanced affinity maturation but impaired antibody persistence. J Immunol 164:4522–4532PubMedGoogle Scholar
  30. Chen J, McLean PA, Neel BG, Okunade G, Shull GE, Wortis HH (2004) CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity. Nat Immunol 5:651–657PubMedGoogle Scholar
  31. Cherukuri A, Carter RH, Brooks S, Bornmann W, Finn R, Dowd CS, Pierce SK (2004a) B-cell signaling is regulated by induced palmitoylation of CD81. J Biol Chem 279:31973–31982PubMedGoogle Scholar
  32. Cherukuri A, Shoham T, Sohn HW, Levy S, Brooks S, Carter R, Pierce SK (2004b) The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B-cell antigen receptor complexes into signaling-active lipid rafts. J Immunol 172:370–380PubMedGoogle Scholar
  33. Collins BE, Blixt O, DeSieno AR, Bovin N, Marth JD, Paulson JC (2004) Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc Natl Acad Sci USA 101:6104–6109PubMedGoogle Scholar
  34. Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC (1998) Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8:497–508PubMedGoogle Scholar
  35. Croix DA, Ahearn JM, Rosengard AM, Han S, Kelsoe G, Ma M, Carroll MC (1996) Antibody response to a T-dependent antigen requires B-cell expression of complement receptors. J Exp Med 183:1857–1864PubMedGoogle Scholar
  36. Delibrias CC, Fischer E, Bismuth G, Kazatchkine MD (1992) Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T-cell line HPB-ALL. J Immunol 149:768–774PubMedGoogle Scholar
  37. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT (1996) C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348–350PubMedGoogle Scholar
  38. Doody GM, Justement LB, Delibrias CC, Matthews RJ, Lin J, Thomas ML, Fearon DT (1995) A role in B-cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269:242–244PubMedGoogle Scholar
  39. Dorken B, Moldenhauer G, Pezzutto A, Schwartz R, Feller A, Kiesel S, Nadler LM (1986) HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol 136:4470–4479PubMedGoogle Scholar
  40. Elhabazi A, Delaire S, Bensussan A, Boumsell L, Bismuth G (2001) Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J Immunol 166:4341–4347PubMedGoogle Scholar
  41. Engel P, Nojima Y, Rothstein D, Zhou LJ, Wilson GL, Kehrl JH, Tedder TF (1993) The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T, B lymphocytes, neutrophils, and monocytes. J Immunol 150:4719–4732PubMedGoogle Scholar
  42. Engel P, Wagner N, Miller AS, Tedder TF (1995a) Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic aciddependent ligand. J Exp Med 181:1581–1586PubMedGoogle Scholar
  43. Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF (1995b) Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39–50PubMedGoogle Scholar
  44. Erickson LD, Tygrett LT, Bhatia SK, Grabstein KH, Waldschmidt TJ (1996) Differential expression of CD22 (Lyb8) on murine B cells. Int Immunol 8:1121–1129PubMedGoogle Scholar
  45. Fang Y, Xu C, Fu YX, Holers VM, Molina H (1998) Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol 160:5273–5279PubMedGoogle Scholar
  46. Fearon DT, Carroll MC (2000) Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 18:393–422PubMedGoogle Scholar
  47. Ferguson AR, Youd ME, Corley RB (2004) Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int Immunol 16:1411–1422PubMedGoogle Scholar
  48. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81:4510–4514PubMedGoogle Scholar
  49. Fischer E, Delibrias C, Kazatchkine MD (1991) Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 146:865–869PubMedGoogle Scholar
  50. Fischer MB, Ma M, Goerg S, Zhou X, Xia J, Finco O, Han S, Kelsoe G, Howard RG, Rothstein TL, Kremmer E, Rosen FS, Carroll MC (1996) Regulation of the B-cell response to Tdependent antigens by classical pathway complement. J Immunol 157:549–556PubMedGoogle Scholar
  51. Fischer MB, Goerg S, Shen L, Prodeus AP, Goodnow CC, Kelsoe G, Carroll MC (1998) Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280:582–585PubMedGoogle Scholar
  52. Fujimoto M, Poe JC, Jansen PJ, Sato S, Tedder TF (1999) CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J Immunol 162:7088–7094PubMedGoogle Scholar
  53. Fujimoto M, Fujimoto Y, Poe JC, Jansen PJ, Lowell CA, DeFranco AL, Tedder TF (2000) CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity 13:47–57PubMedGoogle Scholar
  54. Furuyama T, Inagaki S, Kosugi A, Noda S, Saitoh S, Ogata M, Iwahashi Y, Miyazaki N, Hamaoka T, Tohyama M (1996) Identification of a novel transmembrane semaphorin expressed on lymphocytes. J Biol Chem 271:33376–33381PubMedGoogle Scholar
  55. Gatto D, Pfister T, Jegerlehner A, Martin SW, Kopf M, Bachmann MF (2005) Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1. J Exp Med 201:993–1005PubMedGoogle Scholar
  56. Haas KM, Hasegawa M, Steeber DA, Poe JC, Zabel MD, Bock CB, Karp DR, Briles DE, Weis JH, Tedder TF (2002) Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 17:713–123PubMedGoogle Scholar
  57. Hall KT, Boumsell L, Schultze JL, Boussiotis VA, Dorfman DM, Cardoso AA, Bensussan A, Nadler LM, Freeman GJ (1996) Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci USA 93:11780–11785PubMedGoogle Scholar
  58. Han S, Collins BE, Bengtson P, Paulson JC (2005) Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking. Nat Chem Biol 1:93–97PubMedGoogle Scholar
  59. Hanasaki K, Powell LD, Varki A (1995) Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin. J Biol Chem 270:7543–7550PubMedGoogle Scholar
  60. Hanasaki K, Varki A, Powell LD (1995) CD22-mediated cell adhesion to cytokine-activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins. J Biol Chem 270:7533–7542PubMedGoogle Scholar
  61. Hasegawa M, Fujimoto M, Poe JC, Steeber DA, Lowell CA, Tedder TF (2001) A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice. J Immunol 167:2469–2478PubMedGoogle Scholar
  62. Hennet T, Chui D, Paulson JC, Marth JD (1998) Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci USA 95:4504–4509PubMedGoogle Scholar
  63. Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, Stacker SA, Dunn AR (1995) Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83:301–311PubMedGoogle Scholar
  64. Hokazono Y, Adachi T, Wabl M, Tada N, Amagasa T, Tsubata T (2003) Inhibitory coreceptors activated by antigens but not by anti-Ig heavy chain antibodies install requirement of costimulation through CD40 for survival and proliferation of B cells. J Immunol 171:1835–1843PubMedGoogle Scholar
  65. Horvath G, Serru V, Clay D, Billard M, Boucheix C, Rubinstein E (1998) CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82. J Biol Chem 273:30537–30543PubMedGoogle Scholar
  66. Hu H, Martin BK, Weis JJ, Weis JH (1997) Expression of the murine CD21 gene is regulated by promoter and intronic sequences. J Immunol 158:4758–4768PubMedGoogle Scholar
  67. Illges H, Braun M, Peter HH, Melchers I (1997) Analysis of the human CD21 transcription unit reveals differential splicing of exon 11 in mature transcripts and excludes alternative splicing as the mechanism causing solubilization of CD21. Mol Immunol 34:683–693PubMedGoogle Scholar
  68. Jin L, McLean PA, Neel BG, Wortis HH (2002) Sialic acid binding domains of CD22 are required for negative regulation of B-cell receptor signaling. J Exp Med 195:1199–1205PubMedGoogle Scholar
  69. Kalli KR, Ahearn JM, Fearon DT (1991) Interaction of iC3b with recombinant isotypic and chimeric forms of CR2. J Immunol 147:590–594PubMedGoogle Scholar
  70. Kelm S, Gerlach J, Brossmer R, Danzer CP, Nitschke L (2002) The ligand-binding domain of CD22 is needed for inhibition of the B-cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. J Exp Med 195:1207–1213PubMedGoogle Scholar
  71. Kozmik Z, Wang S, Dorfler P, Adams B, Busslinger M (1992) The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol Cell Biol 12:2662–2672PubMedGoogle Scholar
  72. Krop I, Shaffer AL, Fearon DT, Schlissel MS (1996) The signaling activity of murine CD19 is regulated during cell development. J Immunol 157:48–56PubMedGoogle Scholar
  73. Kumanogoh A, Watanabe C, Lee I, Wang X, Shi W, Araki H, Hirata H, Iwahori K, Uchida J, Yasui T, Matsumoto M, Yoshida K, Yakura H, Pan C, Parnes JR, Kikutani H (2000) Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B-cell signaling. Immunity 13:621–631PubMedGoogle Scholar
  74. Kurtz CB, O’Toole E, Christensen SM, Weis JH (1990) The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J Immunol 144:3581–3591PubMedGoogle Scholar
  75. Lankester AC, van Schijndel GM and van Lier RA (1995) Hematopoietic cell phosphatase is recruited to CD22 following B-cell antigen receptor ligation. J Biol Chem 270:20305–20308PubMedGoogle Scholar
  76. Lanoue A, Batista FD, Stewart M, Neuberger MS (2002) Interaction of CD22 with alpha2,6-linked sialoglycoconjugates: innate recognition of self to dampen B-cell autoreactivity? Eur J Immunol 32:348–355PubMedGoogle Scholar
  77. Law CL, Aruffo A, Chandran KA, Doty RT, Clark EA (1995) Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B, T cells. J Immunol 155:3368–3376PubMedGoogle Scholar
  78. Law CL, Sidorenko SP, Chandran KA, Zhao Z, Shen SH, Fischer EH, Clark EA (1996) CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B-cell activation. J Exp Med 183:547–560PubMedGoogle Scholar
  79. Leprince C, Draves KE, Geahlen RL, Ledbetter JA, Clark EA (1993) CD22 associates with the human surface IgM-B-cell antigen receptor complex. Proc Natl Acad Sci USA 90:3236–3240PubMedGoogle Scholar
  80. Levy S, Todd SC, Maecker HT (1998) CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 16:89–109PubMedGoogle Scholar
  81. Lowe J, Brown B, Hardie D, Richardson P, Ling N (1989) Soluble forms of CD21 and CD23 antigens in the serum in B-cell chronic lymphocytic leukaemia. Immunol Lett 20:103–109PubMedGoogle Scholar
  82. Maecker HT, Levy S (1997) Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J Exp Med 185:1505–1510PubMedGoogle Scholar
  83. Makar KW, Pham CT, Dehoff MH, O’Connor SM, Jacobi SM, Holers VM (1998) An intronic silencer regulates B lymphocyte cell-and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene. J Immunol 160:1268–1278PubMedGoogle Scholar
  84. Martin SW, Goodnow CC (2002) Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory. Nat Immunol 3:182–188PubMedGoogle Scholar
  85. Masilamani M, Kassahn D, Mikkat S, Glocker MO, Illges H (2003) B-cell activation leads to shedding of complement receptor type II (CR2/CD21). Eur J Immunol 33:2391–2397PubMedGoogle Scholar
  86. Matsumoto AK, Kopicky-Burd J, Carter RH, Tuveson DA, Tedder TF, Fearon DT (1991) Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J Exp Med 173:55–64PubMedGoogle Scholar
  87. Matsumoto AK, Martin DR, Carter RH, Klickstein LB, Ahearn JM, Fearon DT (1993) Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J Exp Med 178:1407–1417PubMedGoogle Scholar
  88. Mittelbrunn M, Yanez-Mo M, Sancho D, Ursa A, Sanchez-Madrid F (2002) Cutting edge: dynamic redistribution of tetraspanin CD81 at the central zone of the immune synapse in both T lymphocytes and APC. J Immunol 169:6691–6695PubMedGoogle Scholar
  89. Miyazaki T, Muller U, Campbell KS (1997) Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81. EMBO J 16:4217–4225PubMedGoogle Scholar
  90. Molina H, Kinoshita T, Inoue K, Carel JC, Holers VM (1990) A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors1 and 2. J Immunol 145:2974–2983PubMedGoogle Scholar
  91. Molina H, Holers VM, Li B, Fung Y, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Chaplin DD (1996) Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 93:3357–3361PubMedGoogle Scholar
  92. Nakayama E, von Hoegen I, Parnes JR (1989) Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation. Proc Natl Acad Sci USA 86:1352–1356PubMedGoogle Scholar
  93. Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, Watanabe T, Yamamoto T (1995) Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3:549–560PubMedGoogle Scholar
  94. Nitschke L, Tsubata T (2004) Molecular interactions regulate BCR signal inhibition by CD22 and CD72. Trends Immunol 25:543–550PubMedGoogle Scholar
  95. Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC (1997) CD22 is a negative regulator of B-cell receptor signalling. Curr Biol 7:133–143PubMedGoogle Scholar
  96. Nomura T, Han H, Howard MC, Yagita H, Yakura H, Honjo T, Tsubata T (1996) Antigen receptor-mediated B-cell death is blocked by signaling via CD72 or treatment with dextran sulfate and is defective in autoimmunity-prone mice. Int Immunol 8:867–875PubMedGoogle Scholar
  97. O’Keefe TL, Williams GT, Batista FD, Neuberger MS (1999) Deficiency in CD22, a B cellspecific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 189:1307–1313PubMedGoogle Scholar
  98. O’Keefe TL, Williams GT, Davies SL, Neuberger MS (1996) Hyperresponsive B cells in CD22-deficient mice. Science 274:798–801PubMedGoogle Scholar
  99. O’Rourke LM, Tooze R, Turner M, Sandoval DM, Carter RH, Tybulewicz VL, Fearon DT (1998) CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 8:635–645PubMedGoogle Scholar
  100. Otero DC, Rickert RC (2003) CD19 function in early and late B-cell development. II. CD19 facilitates the pro-B/pre-B transition. J Immunol 171:5921–5930PubMedGoogle Scholar
  101. Otero DC, Omori SA, Rickert RC (2001) Cd19-dependent activation of Akt kinase in Blymphocytes. J Biol Chem 276:1474–1478PubMedGoogle Scholar
  102. Otero DC, Anzelon AN, Rickert RC (2003) CD19 function in early and late B-cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals. J Immunol 170:73–83PubMedGoogle Scholar
  103. Otipoby KL, Andersson KB, Draves KE, Klaus SJ, Farr AG, Kerner JD, Perlmutter RM, Law CL, Clark EA (1996) CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384:634–637PubMedGoogle Scholar
  104. Otipoby KL, Draves KE, Clark EA (2001) CD22 regulates B-cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1. J Biol Chem 276:44315–44322PubMedGoogle Scholar
  105. Pan C, Baumgarth N, Parnes JR (1999) CD72-deficient mice reveal nonredundant roles of CD72 in B-cell development and activation. Immunity 11:495–506PubMedGoogle Scholar
  106. Parnes JR, Pan C (2000) CD72, a negative regulator of B-cell responsiveness. Immunol Rev 176:75–85PubMedGoogle Scholar
  107. Peaker CJ, Neuberger MS (1993) Association of CD22 with the B-cell antigen receptor. Eur J Immunol 23:1358–1363PubMedGoogle Scholar
  108. Pesando JM, Bouchard LS, McMaster BE (1989) CD19 is functionally and physically associated with surface immunoglobulin. J Exp Med 170:2159–2164PubMedGoogle Scholar
  109. Pezzutto A, Dorken B, Moldenhauer G, Clark EA (1987) Amplification of human B-cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140. J Immunol 138:98–103PubMedGoogle Scholar
  110. Pezzutto A, Rabinovitch PS, Dorken B, Moldenhauer G, Clark EA (1988) Role of the CD22 human B-cell antigen in B-cell triggering by anti-immunoglobulin. J Immunol 140:1791–1795PubMedGoogle Scholar
  111. Pflugh DL, Maher SE, Bothwell AL (2002) Ly-6 superfamily members Ly-6A/E, Ly-6C, and Ly-6I recognize two potential ligands expressed by B lymphocytes. J Immunol 169:5130–5136PubMedGoogle Scholar
  112. Poe JC, Fujimoto M, Jansen PJ, Miller AS, Tedder TF (2000) CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux. J Biol Chem 275:17420–17427PubMedGoogle Scholar
  113. Poe JC, Fujimoto Y, Hasegawa M, Haas KM, Miller AS, Sanford IG, Bock CB, Fujimoto M, Tedder TF (2004) CD22 regulates B lymphocyte function in vivo through both liganddependent and ligand-independent mechanisms. Nat Immunol 5:1078–1087PubMedGoogle Scholar
  114. Powell LD, Varki A (1994) The oligosaccharide binding specificities of CD22 beta, a sialic acidspecific lectin of B cells. J Biol Chem 269:10628–10636PubMedGoogle Scholar
  115. Powell LD, Sgroi D, Sjoberg ER, Stamenkovic I, Varki A (1993) Natural ligands of the B-cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition. J Biol Chem 268:7019–7027PubMedGoogle Scholar
  116. Powell LD, Jain RK, Matta KL, Sabesan S, Varki A (1995) Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22. Evidence for a minimal structural recognition motif and the potential importance of multisite binding. J Biol Chem 270:7523–7532PubMedGoogle Scholar
  117. Pramoonjago P, Takeda J, Kim YU, Inoue K, Kinoshita T (1993) Ligand specificities of mouse complement receptor types 1 (CR1) and 2 (CR2) purified from spleen cells. Int Immunol 5:337–343PubMedGoogle Scholar
  118. Qin D, Wu J, Carroll MC, Burton GF, Szakal AK, Tew JG (1998) Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses. J Immunol 161:4549–4554PubMedGoogle Scholar
  119. Razi N, Varki A (1998) Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc Natl Acad Sci USA 95:7469–7474PubMedGoogle Scholar
  120. Razi N, Varki A (1999) Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. Glycobiology 9:1225–1234PubMedGoogle Scholar
  121. Reid RR, Woodcock S, Shimabukuro-Vornhagen A, Austen WG, Jr., Kobzik L, Zhang M, Hechtman HB, Moore FD, Jr. and Carroll MC (2002) Functional activity of natural antibody is altered in Cr2-deficient mice. J Immunol 169:5433–5440PubMedGoogle Scholar
  122. Reynes M, Aubert JP, Cohen JH, Audouin J, Tricottet V, Diebold J, Kazatchkine MD (1985) Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J Immunol 135:2687–2694PubMedGoogle Scholar
  123. Rickert RC (2005) Regulation of B lymphocyte activation by complement C3 and the B-cell coreceptor complex. Curr Opin Immunol 17:237–243PubMedGoogle Scholar
  124. Rickert RC, Rajewsky K, Roes J (1995) Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352–355PubMedGoogle Scholar
  125. Samardzic T, Marinkovic D, Danzer CP, Gerlach J, Nitschke L, Wirth T (2002) Reduction of marginal zone B cells in CD22-deficient mice. Eur J Immunol 32:561–567PubMedGoogle Scholar
  126. Sato S, Steeber DA, Tedder TF (1995) The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc Natl Acad Sci USA 92:11558–11562PubMedGoogle Scholar
  127. Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang ML, Tedder TF (1996) CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 5:551–562PubMedGoogle Scholar
  128. Schulte RJ, Campbell MA, Fischer WH, Sefton BM (1992) Tyrosine phosphorylation of CD22 during B-cell activation. Science 258:1001–1004PubMedGoogle Scholar
  129. Sgroi D, Varki A, Braesch-Andersen S, Stamenkovic I (1993) CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. J Biol Chem 268:7011–7018PubMedGoogle Scholar
  130. Shi W, Kumanogoh A, Watanabe C, Uchida J, Wang X, Yasui T, Yukawa K, Ikawa M, Okabe M, Parnes JR, Yoshida K, Kikutani H (2000) The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B, T-cell activation in CD100-deficient mice. Immunity 13:633–642PubMedGoogle Scholar
  131. Shoham T, Rajapaksa R, Boucheix C, Rubinstein E, Poe JC, Tedder TF, Levy S (2003) The tetraspanin CD81 regulates the expression of CD19 during B-cell development in a postendoplasmic reticulum compartment. J Immunol 171:4062–4072PubMedGoogle Scholar
  132. Sjoberg ER, Powell LD, Klein A, Varki A (1994) Natural ligands of the B-cell adhesion molecule CD22 beta can be masked by 9-O-acetylation of sialic acids. J Cell Biol 126:549–562PubMedGoogle Scholar
  133. Smith KG, Tarlinton DM, Doody GM, Hibbs ML, Fearon DT (1998) Inhibition of the B-cell by CD22: a requirement for Lyn. J Exp Med 187:807–811PubMedGoogle Scholar
  134. Stamenkovic I, Seed B (1988) CD19, the earliest differentiation antigen of the B-cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus-related cytoplasmic tail. J Exp Med 168:1205–1210PubMedGoogle Scholar
  135. Stamenkovic I, Seed B (1990) The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature 345:74–77PubMedGoogle Scholar
  136. Stamenkovic I, Sgroi D, Aruffo A, Sy MS, Anderson T (1991) The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell 66:1133–1144PubMedGoogle Scholar
  137. Subbarao B, Mosier DE (1984) Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies. J Exp Med 159:1796–1801PubMedGoogle Scholar
  138. Takahashi S, Doss C, Levy S, Levy R (1990) TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen. J Immunol 145:2207–2213PubMedGoogle Scholar
  139. Takahashi Y, Ohta H, Takemori T (2001) Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B-cell repertoire. Immunity 14:181–192PubMedGoogle Scholar
  140. Tedder TF, Isaacs CM (1989) Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J Immunol 143: 712–717PubMedGoogle Scholar
  141. Tedder TF, Clement LT, Cooper MD (1984) Expression of C3d receptors during human B-cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J Immunol 133:678–683PubMedGoogle Scholar
  142. Tedder TF, Inaoki M, Sato S (1997) The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6:107–118PubMedGoogle Scholar
  143. Tsitsikov EN, Gutierrez-Ramos JC, Geha RS (1997) Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice. Proc Natl Acad Sci USA 94:10844–10849PubMedGoogle Scholar
  144. Tuveson DA, Ahearn JM, Matsumoto AK, Fearon DT (1991) Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex. J Exp Med 173:1083–1089PubMedGoogle Scholar
  145. Tuveson DA, Carter RH, Soltoff SP, Fearon DT (1993) CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260:986–989PubMedGoogle Scholar
  146. Van de Velde H, von Hoegen I, Luo W, Parnes JR, Thielemans K (1991) The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 351:662–665PubMedGoogle Scholar
  147. van der Merwe PA, Crocker PR, Vinson M, Barclay AN, Schauer R, Kelm S (1996) Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22. J Biol Chem 271:9273–9280PubMedGoogle Scholar
  148. Vigorito E, Bardi G, Glassford J, Lam EW, Clayton E, Turner M (2004) Vav-dependent and vavindependent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus. J Immunol 173:3209–3214PubMedGoogle Scholar
  149. Wakabayashi C, Adachi T, Wienands J, Tsubata T (2002) A distinct signaling pathway used by the IgG-containing B-cell antigen receptor. Science 298:2392–2395PubMedGoogle Scholar
  150. Wang Y, Brooks SR, Li X, Anzelon AN, Rickert RC, Carter RH (2002) The physiologic role of CD19 cytoplasmic tyrosines. Immunity 17:501–514PubMedGoogle Scholar
  151. Wienands J, Freuler F, Baumann G (1995) Tyrosine-phosphorylated forms of Ig beta, CD22, TCR zeta and HOSS are major ligands for tandem SH2 domains of Syk. Int Immunol 7: 1701–1708PubMedGoogle Scholar
  152. Wilson GL, Fox CH, Fauci AS, Kehrl JH (1991) cDNA cloning of the B-cell membrane protein CD22: a mediator of B-B-cell interactions. J Exp Med 173:137–146PubMedGoogle Scholar
  153. Wu Y, Nadler MJ, Brennan LA, Gish GD, Timms JF, Fusaki N, Jongstra-Bilen J, Tada N, Pawson T, Wither J, Neel BG, Hozumi N (1998) The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1. Curr Biol 8:1009–1017PubMedGoogle Scholar
  154. Wu X, Jiang N, Deppong C, Singh J, Dolecki G, Mao D, Morel L, Molina HD (2002) A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus. J Immunol 169:1587–1592PubMedGoogle Scholar
  155. Xu Y, Beavitt SJ, Harder KW, Hibbs ML, Tarlinton DM (2002) The activation and subsequent regulatory roles of Lyn and CD19 after B-cell receptor ligation are independent. J Immunol 169:6910–6918PubMedGoogle Scholar
  156. Yohannan J, Wienands J, Coggeshall KM, Justement LB (1999) Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B-cell co-receptor CD22. J Biol Chem 274:18769–18776PubMedGoogle Scholar
  157. Zhang M, Varki A (2004) Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis. Glycobiology 14:939–949PubMedGoogle Scholar
  158. Zhou LJ, Ord DC, Hughes AL, Tedder TF (1991) Structure and domain organization of the CD19 antigen of human, mouse, and guinea pig B lymphocytes. Conservation of the extensive cytoplasmic domain. J Immunol 147:1424–1432PubMedGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Kozo Watanabe
    • 1
  • Takeshi Tsubata
    • 1
  1. 1.Laboratory of Immunology, School of Biomedical Science, and Department of Immunology, Medical Research InstituteTokyo Medical and Dental UniversityTokyoJapan

Personalised recommendations